A Prospective Study of Risperdal (Risperidone) for the Treatment of

Status Completed

Clinical Trial Summary

The purpose of this study is to assess whether risperidone (an antipsychotic medication) is safe and effective in treating behaviour disorder in learning disabled children, which does not improve with psychological therapy.

Clinical Trial Description

There is a high incidence of behaviour disorder in people who are learning disabled. The purpose of this study is to assess whether risperidone is safe and effective in the treatment of learning disabled children diagnosed with behaviour disorder, which does not improve with psychological therapy. If the learning disability is very severe, or the behaviour disorder is very severe, such therapy is not appropriate and thus is not attempted; these patients are nevertheless eligible to participate in the study. At the beginning of treatment, the dose of risperidone is titrated, by gradual increase from 0.25 mg/day up to a maximum of 4 mg/day, based on therapeutic response, with decreases allowed in case of adverse reactions. Patients will be assessed over six months. The primary measure of effectiveness is the change compared to baseline in the total score on the Aberrant Behaviour Checklist (ABC). The EPSS is used to monitor the appearance of extrapyramidal symptoms. Based on results from other studies and the differences observed as a result of treatment, the investigator and his team expect to be able to detect a statistically and clinically significant result if data are available for 15 evaluable patients. Twenty patients will be recruited, taking account of possible drop outs. 0.25 mg of risperidone per day, taken orally, up to a maximum daily dose of 4 mg/day, for a treatment period of 6 months. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00254930
Study type	Interventional
Source	Janssen-Cilag Ltd.
Contact
Status	Completed
Phase	Phase 3
Start date	September 2003
Completion date	June 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05525962` - Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolescents in Child Welfare System.
Not yet recruiting	`NCT04418921` - Improving Self-regulation in Children With Neurodevelopmental Disorders:	N/A
Recruiting	`NCT05637320` - Big Feelings: A Study on Children's Emotions in Therapy	N/A
Completed	`NCT04610281` - The Inner Garden and Care for Children With Moderate to Severe Agitation	N/A
Completed	`NCT03448575` - Safer Use of Antipsychotics in Youth	N/A
Completed	`NCT02030730` - RCT of Brief Universal Parenting Program to Prevent Child Behavioural and Emotional Difficulties in Greece	N/A
Completed	`NCT01554527` - Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children	N/A
Completed	`NCT00558454` - Iron Supplementation of Marginally Low Birth Weight Infants	Phase 4
Completed	`NCT05240222` - Pre-Implementation Enhancement Strategy To Improve Teachers' Intention to Implement Evidence-Based Practices	N/A
Completed	`NCT02778022` - Child Adult Relationship Enhancement in Pediatric Primary Care Parenting Group to Reduce Child Behavior Problems	N/A
Completed	`NCT03065517` - VillageWhere: Innovative Mobile Technology for Youth With Conduct Disorder and Their Parents	N/A
Completed	`NCT03927612` - Virtual Reality to Improve Social Perspective Taking	N/A
Enrolling by invitation	`NCT05179759` - Teachers Leading the Frontlines (Tealeaf) - a Hybrid Effectiveness, Implement, and Context Trial	N/A
Recruiting	`NCT05262088` - Prognostic Value of Generalized Movements in the Diagnosis of Neurological Diseases in Children
Completed	`NCT04723277` - Efficacy of Teacher-delivered Child Mental Healthcare in Primary Schools of India	N/A
Recruiting	`NCT05206708` - Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old	N/A
Not yet recruiting	`NCT04745819` - Epidemiological Screening of Psychiatric Disorders Among School Aged Children and Adolescent in Assiut Governorate
Not yet recruiting	`NCT04762394` - Epidemiology of Psychiatric Disorders in Children and Adolescent at Egypt
Completed	`NCT02250339` - A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric Disorders
Recruiting	`NCT03300713` - MOther-Child Interaction Assessment TRAINING for Pediatricians	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms